Offer - Urjas Oil for just ₹ 1 X
Voage M is an allopathic medicine The correct dosage of Voage M depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Voage M is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Voage M safe for pregnant women?
Pregnant women may get severe side effects after taking Voage M. If you are pregnant, do not take Voage M without a doctor's advice.
Is the use of Voage M safe during breastfeeding?
There is no research available on the side effects of Voage M in breastfeeding women. Therefore, its impact is unknown.
What is the effect of Voage M on the Kidneys?
There may be some adverse effects on kidney after taking Voage M. If you observe any such side effects, stop taking this drug. Consume this medicine again only if your doctor advises you to do so.
What is the effect of Voage M on the Liver?
You may experience side effects on your liver after taking Voage M. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Voage M on the Heart?
There is no research available on the side effects of Voage M on the heart. Therefore, its impact is unknown.
Voage M should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Voage M unless your doctor advises you to do so -
Is this Voage M habit forming or addictive?
Voage M is not addictive in nature.
Interaction between Food and Voage M
Due to the absence of research, it is difficult to say how Voage M and food will interact.
Interaction between Alcohol and Voage M
Consumption of alcohol and Voage M together may have severe effects on your health.
The long-term use can lead to the deficiency of Vitamin B12, which can further lead to megaloblastic anemia. Furthermore, Long-term Metformin use can also lead to kidney and liver problems.
Yes, you can take Voage M with a beta-blocker. People with diabetes tend to develop heart disease or stroke at an earlier age than the general population. One reason for this is that high glucose levels increase your risk of high blood pressure (hypertension). No harmful interactions are seen between them. However, a recent study suggests that beta-blockers can decrease the plasma level of Voage M and long-term use can increase lactic acid and uric acid in the blood.
Yes, Voage M can cause low blood sugar (hypoglycemia). However, this can also occur if you delay or miss a meal, drink alcohol, exercise more than usual, can't eat due to stomach upset, and taking other antidiabetic medicine with metformin. So, regular monitoring of blood glucose level is needed and be cautious of symptoms of hypoglycemia, always keep glucose-rich food with you.
Voage M is used with a proper diet and exercise program, to treat diabetes. It is also used with other medication to reduce the high blood sugar. It is used in a patient with type2 diabetes. It is also used in the treatment of polycystic ovarian syndrome (PCOS) and cancer.
Yes, Voage M can be taken with the statin. There is no serious or harmful interaction have been observed between them. Some studies say that it's possible your blood sugar (blood glucose) level may increase when you take a statin, which may lead to developing type 2 diabetes. The risk is small but important enough that the Food and Drug Administration (FDA) has issued a warning on statin labels regarding blood glucose levels and diabetes.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Farxiga (dapagliflozin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 278